CO2023017971A2 - Composiciones veterinarias apetecibles - Google Patents

Composiciones veterinarias apetecibles

Info

Publication number
CO2023017971A2
CO2023017971A2 CONC2023/0017971A CO2023017971A CO2023017971A2 CO 2023017971 A2 CO2023017971 A2 CO 2023017971A2 CO 2023017971 A CO2023017971 A CO 2023017971A CO 2023017971 A2 CO2023017971 A2 CO 2023017971A2
Authority
CO
Colombia
Prior art keywords
palatable
veterinary compositions
pyrantel
excipients
directed
Prior art date
Application number
CONC2023/0017971A
Other languages
English (en)
Inventor
Sharon Cruz Martin
Isabela Ewa Galeska
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CO2023017971A2 publication Critical patent/CO2023017971A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención está dirigida a una composición veterinaria masticable estable, eficaz y apetecible que comprende como principio activo un compuesto de isoxazolina de Fórmula (I), una lactona macrocíclica estabilizada, pirantel y excipientes.
CONC2023/0017971A 2021-06-25 2023-12-20 Composiciones veterinarias apetecibles CO2023017971A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21181879 2021-06-25
PCT/EP2022/067362 WO2022269042A1 (en) 2021-06-25 2022-06-24 Palatable veterinary compositions

Publications (1)

Publication Number Publication Date
CO2023017971A2 true CO2023017971A2 (es) 2024-03-07

Family

ID=76662391

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0017971A CO2023017971A2 (es) 2021-06-25 2023-12-20 Composiciones veterinarias apetecibles

Country Status (8)

Country Link
EP (1) EP4358941A1 (es)
KR (1) KR20240025534A (es)
CN (1) CN117545473A (es)
AU (1) AU2022296860A1 (es)
BR (1) BR112023027372A2 (es)
CA (1) CA3222397A1 (es)
CO (1) CO2023017971A2 (es)
WO (1) WO2022269042A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803836D0 (en) 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
EA011764B1 (ru) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Изоксазолинзамещённое производное бензамида и пестицид
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
NZ548931A (en) 2006-05-15 2008-03-28 Wyeth Corp Stabilised formulation of moxidectin
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
CN101743000A (zh) 2007-06-27 2010-06-16 杜邦公司 动物虫害控制方法
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
US8383659B2 (en) 2008-12-19 2013-02-26 Novartis Ag Isoxazoline derivatives as pesticides
ES2569486T3 (es) 2009-12-17 2016-05-11 Merial, Inc. Compuestos de dihidroazol antiparasitarios y composiciones que comprenden los mismos
WO2011124998A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
US11896594B2 (en) * 2018-09-05 2024-02-13 Zoetis Services Llc Palatable antiparasitic formulations
CN116507327A (zh) * 2020-09-03 2023-07-28 礼蓝动物保健有限公司 可咀嚼调配物
EP4208157A1 (en) * 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations

Also Published As

Publication number Publication date
CN117545473A (zh) 2024-02-09
WO2022269042A1 (en) 2022-12-29
EP4358941A1 (en) 2024-05-01
KR20240025534A (ko) 2024-02-27
CA3222397A1 (en) 2022-12-29
BR112023027372A2 (pt) 2024-03-12
AU2022296860A1 (en) 2023-12-14

Similar Documents

Publication Publication Date Title
CL2020000739A1 (es) Agente prolongado de control de ectoparasito para animales.
CL2017002936A1 (es) Compuestos ciclooctadepsipéptidos, composición veterinaria antihelmíntica, y uso para preparar un medicamento útil contra infección por parásitos o una infestación por parásitos internos o externos en un animal.
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
GEP201706772B (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
CO2021005226A2 (es) Nuevos compuestos antihelmínticos
BR112017027147A2 (pt) agente estimulante de restauração/crescimento de cabelo
PH12021550338A1 (en) Palatable antiparasitic formulations
NZ736374A (en) Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
CO2020013876A2 (es) Nuevos derivados de quinolina
AR060132A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
BR112021026487A2 (pt) Composto de isoxazolina e aplicação do mesmo
UY38591A (es) Compuestos de diona cíclica herbicidamente activos que comprenden un grupo oxima o hidrazona.
UY37577A (es) Dihidroimidazopiridindionas sustituidas
MX2023002666A (es) Formulaciones masticables.
ECSP23077322A (es) Derivados de fósforo como nuevos inhibidores de sos1
EA201890906A1 (ru) ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
ECSP20063701A (es) Formulación sólida de mezclas insecticidas
CO2022018655A2 (es) Compuestos heterocíclicos como anthelmínticos
PE20211006A1 (es) Derivados de azitromicina y roxitromicina como farmacos senoliticos
UY38578A (es) Compuestos de diona cíclicos activos como herbicidas que comprenden un grupo oxamida
CO2023017971A2 (es) Composiciones veterinarias apetecibles
MX2023002671A (es) Formulaciones agradables.
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
CO2022016630A2 (es) Composiciones farmacéuticas inyectables y usos de las mismas
ECSP20064651A (es) Formulación sólida de mezclas insecticidas